« Back
Clinical Biowavier Program
Poster Title: Clinical Biowavier Program
Submitted on 23 Apr 2021
Author(s): In-Vitro Team
This poster was presented at Stabicon
Poster Views: 66
View poster »

Poster Information
Abstract: Our solution on in vitro analyses can provide proof of concept on delivery dosage form in the early stages or reverse pharmacology development of the active process, when the selectivity and possible interactions of the candidate drug towards the desired therapeutic target are established.Summary: In vitro studies are critical to drug and wellness product development due to their ability to provide a basis for clinical in vivo studies for predicting best delivery model to take Go/No-Go decision.References: abuse »
Ask the author a question about this poster.
Ask a Question »

Creative Commons

Related Posters

Grid turbulence studied by Particle Image Velocimetry
Duda, D. and Bém, J. and Yanovych, V. and Uruba, V.

Concept to commercialization Health& Wellness Product
Business Development Team

Orally Inhaled & Nasal Drug
Business Development Team

Nutraceutical Product
Business Development Team

Introduction of SARS-CoV-2 Vaccines
Candy Swift